Publications
https://www.ncbi.nlm.nih.gov/myncbi/sophie.astrof.2/bibliography/public/
2023 – 2024
Arriagada C, Lin E, Schonning M., Astrof S. Mesodermal fibronectin controls cell shape, polarity, and mechanotransduction in the second heart field during cardiac outflow tract development. Developmental Cell (2024), https://doi.org/10.1016/j.devcel.2024.09.017
Ramirez A, Vyzas CA, Zhao H, Eng K, Degenhardt K, Astrof S. Buffering Mechanism in Aortic Arch Artery Formation and Congenital Heart Disease. Circulation Research Volume 134, Issue 10, 10 May 2024; Pages e112-e132, DOI: https://doi.org/10.1161/CIRCRESAHA.123.322767
Alexander BE, Zhao H, and Astrof S. SMAD4: A critical regulator of cardiac neural crest cell fate and vascular smooth muscle development. Dev. Dyn. 2023 Aug 31, doi: 10.1002/dvdy.652
Astrof S, Arriagada C, Saijoh Y, Francou A, Kelly RG, Moon A. Aberrant differentiation of second heart field mesoderm prefigures cellular defects in the outflow tract in response to loss of FGF8. Dev Biol 499:10-21, 2023
Cell Rep. 2023 May 4;42(5):112473. doi: 10.1016/j.celrep.2023.112473. PMID: 37148241
2020 – 2022
. DOI: 10.1242/jcs.260120. See also: Research Highlight and First author interview
Dev Cell. 2022 Mar 28;57(6):767-782.e6. DOI: 10.1016/j.devcel.2022.02.015. Epub 2022 Mar 10.PMID: 35276066
2010 – 2019
Biochim Biophys Acta Gene Regul Mech. 2019 Oct;1862(10):194436. doi: 10.1016/j.bbagrm.2019.194436. Epub 2019 Nov 1.PMID: 31682939
Isolation of Mouse Cardiac Neural Crest Cells and Their Differentiation into Smooth Muscle Cells. Bio Protoc. 2017 Sep 5;7(17). doi: 10.21769/BioProtoc.2530. PubMed PMID: 28979923; PubMed Central PMCID: PMC5624110.
Endothelium in the pharyngeal arches 3, 4 and 6 is derived from the second heart field. Dev Biol. 2017 Jan 15;421(2):108-117. doi: 10.1016/j.ydbio.2016.12.010. Epub 2016 Dec 9. PubMed PMID: 27955943; PubMed Central PMCID: PMC5221477.
Neural crest cell-autonomous roles of fibronectin in cardiovascular development. Development. 2016 Jan 1;143(1):88-100. doi: 10.1242/dev.125286. Epub 2015 Nov 9. PubMed PMID: 26552887; PubMed Central PMCID: PMC4725203.
Fibronectin signals through integrin α5β1 to regulate cardiovascular development in a cell type-specific manner. Dev Biol. 2015 Nov 15;407(2):195-210. doi: 10.1016/j.ydbio.2015.09.016. Epub 2015 Oct 3. PubMed PMID: 26434918; PubMed Central PMCID: PMC5312697.
Mesodermal expression of integrin α5β1 regulates neural crest development and cardiovascular morphogenesis. Dev Biol. 2014 Nov 15;395(2):232-44. doi: 10.1016/j.ydbio.2014.09.014. Epub 2014 Sep 19. PubMed PMID: 25242040; PubMed Central PMCID: PMC4252364.
Shape and position of the node and notochord along the bilateral plane of symmetry are regulated by cell-extracellular matrix interactions. Biol Open. 2014 Jun 13;3(7):583-90. doi: 10.1242/bio.20148243. PubMed PMID: 24928429; PubMed Central PMCID: PMC4154294.
PI3K/Akt1 signalling specifies foregut precursors by generating regionalized extra-cellular matrix. Elife. 2013 Dec 24;2:e00806. doi: 10.7554/eLife.00806. PubMed PMID: 24368729; PubMed Central PMCID: PMC3871052.
Fibronectin and integrin alpha 5 play requisite roles in cardiac morphogenesis. Dev Biol. 2013 Sep 1;381(1):73-82. doi: 10.1016/j.ydbio.2013.06.010. Epub 2013 Jun 17. PubMed PMID: 23791818; PubMed Central PMCID: PMC3833817.
Essential roles of fibronectin in the development of the left-right embryonic body plan. Dev Biol. 2011 Jun 15;354(2):208-20. doi: 10.1016/j.ydbio.2011.03.026. Epub 2011 Apr 3. PubMed PMID: 21466802; PubMed Central PMCID: PMC3225965.
Fibronectin and integrin alpha 5 play essential roles in the development of the cardiac neural crest. Mech Dev. 2010 Sep-Dec;127(9-12):472-84. doi: 10.1016/j.mod.2010.08.005. Epub 2010 Aug 31. PubMed PMID: 20807571; PubMed Central PMCID: PMC3233353.
2004 – 2009
Fibronectins in vascular morphogenesis. Angiogenesis. 2009;12(2):165-75. doi: 10.1007/s10456-009-9136-6. Epub 2009 Feb 14. Review. PubMed PMID: 19219555; PubMed Central PMCID: PMC2716138.
A system for Cre-regulated RNA interference in vivo. Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13895-900. doi: 10.1073/pnas.0806907105. Epub 2008 Sep 8. PubMed PMID: 18779577; PubMed Central PMCID: PMC2532697.
Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev Biol. 2007 Nov 1;311(1):11-24. doi: 10.1016/j.ydbio.2007.07.005. Epub 2007 Jul 12. PubMed PMID: 17706958; PubMed Central PMCID: PMC2080666.
Heart development in fibronectin-null mice is governed by a genetic modifier on chromosome four. Mech Dev. 2007 Aug;124(7-8):551-8. doi: 10.1016/j.mod.2007.05.004. Epub 2007 Jun 2. PubMed PMID: 17628448.
Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1391-6. doi: 10.1161/01.ATV.0000216282.58291.c6. Epub 2006 Mar 9. PubMed PMID: 16528004.
Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis. Mol Cell Biol. 2004 Oct;24(19):8662-70. doi: 10.1128/MCB.24.19.8662-8670.2004. PubMed PMID: 15367684; PubMed Central PMCID: PMC516752.
1998 – 2002
Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein. Virology. 2002 Jan 5;292(1):150-5. doi: 10.1006/viro.2001.1314. PubMed PMID: 11878917.
Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein. J Virol. 2001 Feb;75(3):1571-5. doi: 10.1128/JVI.75.3.1571-1575.2001. PubMed PMID: 11152532; PubMed Central PMCID: PMC114065.
A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor. J Virol. 2000 Oct;74(20):9540-5. doi: 10.1128/jvi.74.20.9540-9545.2000. PubMed PMID: 11000224; PubMed Central PMCID: PMC112384.
Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9867-72. doi: 10.1073/pnas.96.17.9867. PubMed PMID: 10449786; PubMed Central PMCID: PMC22302.
Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7063-8. doi: 10.1073/pnas.95.12.7063. PubMed PMID: 9618539; PubMed Central PMCID: PMC22739.